摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,4,6-tetra-O-pivaloyl-β-D-galactopyranosyl trichloroacetimidate | 670249-42-0

中文名称
——
中文别名
——
英文名称
2,3,4,6-tetra-O-pivaloyl-β-D-galactopyranosyl trichloroacetimidate
英文别名
O-(2,3,4,6-tetra-O-pivaloyl-β-D-galactopyranosyl)trichloroacetimidate;pivaloyl(-2)[pivaloyl(-3)][pivaloyl(-4)][pivaloyl(-6)]Gal(b)-O-C(NH)CCl3;[(2R,3S,4S,5R,6S)-3,4,5-tris(2,2-dimethylpropanoyloxy)-6-(2,2,2-trichloroethanimidoyl)oxyoxan-2-yl]methyl 2,2-dimethylpropanoate
2,3,4,6-tetra-O-pivaloyl-β-D-galactopyranosyl trichloroacetimidate化学式
CAS
670249-42-0
化学式
C28H44Cl3NO10
mdl
——
分子量
661.017
InChiKey
WOSWCYLUSZNKFK-ICUGJSFKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.2
  • 重原子数:
    42
  • 可旋转键数:
    15
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    148
  • 氢给体数:
    1
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2S,3R,4E)-2-azido-3-benzoyloxy-4-octadecen-1-ol2,3,4,6-tetra-O-pivaloyl-β-D-galactopyranosyl trichloroacetimidate三氟化硼乙醚 作用下, 以 二氯甲烷 为溶剂, 以88%的产率得到(2S,3R,4E)-2-azido-3-benzoyloxy-1-(2,3,4,6-tetra-O-pivaloyl-β-D-galactopyranosyloxy)octadec-4-ene
    参考文献:
    名称:
    CD1a-binding glycosphingolipids stimulating human autoreactive T-cells: synthesis of a family of sulfatides differing in the acyl chain moiety
    摘要:
    Native sulfatide (a mixture of 3-sulfated beta-D-galactopyranosylceramides with different fatty acids at the ceramide moiety) is an antigen presented by CD1a proteins. Herein the preparation of four sulfatides, which are constituents of the natural mixture and bear palmitic, stearic, behenic or nervonic fatty acid chains, is described. Azidosphingosine was stereoselectively synthesized through a CuCN-catalyzed allylic alkylation of a hexenitol dimesylate derived from D-xylose; beta-glycosylation of azidosphingosine, with a suitable D-galactosyl trichloroacetimidate led, after reduction of the azido, group, to the galactosylsphingosine skeleton, which was derivatized with the different fatty acids. Final regioselective 3-sulfation gave the desired sulfatides, which were tested for activation of sulfatide-specific and CD1a-restricted T-cell clones. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(02)01092-x
  • 作为产物:
    参考文献:
    名称:
    Regioselective Glycosylation of Glucosamine and Galactosamine Derivates Using O-Pivaloyl Galactosyl Donors
    摘要:
    Penta-O-pivaloyl-galactopyranose和tetra-O-pivaloyl-galactopyranosyl溴在亲电活化后与6-O-保护的2-azido-galactosides反应,高选择性地形成Thomsen-Friedenreich抗原二糖的前体结构,但产率较低。使用4,6-Obenzylidene保护的2-azidogalactosides和2-O-pivaloyl苯硫基半乳苷,可以得到这种类型的T-抗原二糖,产率较高。4,6-O-benzylidene保护的葡萄糖氨基衍生物与O-pivaloyl保护的半乳苷溴的糖基化反应有效地产生了乳糖氨二糖。甚至通过这种方法,一种硫代糖苷也可以有效地被半乳苷化,形成一种作为潜在糖基供体的二糖硫代糖苷。
    DOI:
    10.1515/znb-2003-0808
点击查看最新优质反应信息

文献信息

  • Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
    申请人:Fushimi Nobuhiko
    公开号:US20060247179A1
    公开(公告)日:2006-11-02
    The present invention provides fused heterocyclic derivatives represented by the general formula: wherein R 1 represents H, halogen, OH, etc.; R 2 represents H, halogen or an alkyl group; R 3 and R 4 represent H, OH, halogen, etc.; Q represents alkylene, etc.; ring A represents aryl or heteroaryl; and G represents , or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity, pharmaceutical compositions comprising the same, and pharmaceutical uses thereof.
    本发明提供了由通式表示的融合杂环衍生物:其中R1代表H、卤素、OH等;R2代表H、卤素或烷基;R3和R4代表H、OH、卤素等;Q代表烷基等;环A代表芳基或杂芳基;G代表,或其药学上可接受的盐,或其前药,它们在人类SGLT中表现出优异的抑制活性,并且可用作预防或治疗与高血糖有关的疾病,如糖尿病、餐后高血糖、糖耐量受损、糖尿病并发症或肥胖症的药剂,以及它们的药用组合物和药用用途。
  • FUSED HETEROCYCLIC DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF
    申请人:Kissei Pharmaceutical Co., Ltd.
    公开号:EP1609798B1
    公开(公告)日:2012-05-09
  • US7566699B2
    申请人:——
    公开号:US7566699B2
    公开(公告)日:2009-07-28
  • CD1a-binding glycosphingolipids stimulating human autoreactive T-cells: synthesis of a family of sulfatides differing in the acyl chain moiety
    作者:Federica Compostella、Laura Franchini、Gennaro De Libero、Giovanni Palmisano、Fiamma Ronchetti、Luigi Panza
    DOI:10.1016/s0040-4020(02)01092-x
    日期:2002.10
    Native sulfatide (a mixture of 3-sulfated beta-D-galactopyranosylceramides with different fatty acids at the ceramide moiety) is an antigen presented by CD1a proteins. Herein the preparation of four sulfatides, which are constituents of the natural mixture and bear palmitic, stearic, behenic or nervonic fatty acid chains, is described. Azidosphingosine was stereoselectively synthesized through a CuCN-catalyzed allylic alkylation of a hexenitol dimesylate derived from D-xylose; beta-glycosylation of azidosphingosine, with a suitable D-galactosyl trichloroacetimidate led, after reduction of the azido, group, to the galactosylsphingosine skeleton, which was derivatized with the different fatty acids. Final regioselective 3-sulfation gave the desired sulfatides, which were tested for activation of sulfatide-specific and CD1a-restricted T-cell clones. (C) 2002 Elsevier Science Ltd. All rights reserved.
  • Regioselective Glycosylation of Glucosamine and Galactosamine Derivates Using O-Pivaloyl Galactosyl Donors
    作者:Mathia Oßwald、Uwe Lang、Siglinde Friedrich-Bochnitschek、Waldemar Pfrengle、Horst Kunz
    DOI:10.1515/znb-2003-0808
    日期:2003.8.1

    Penta-O-pivaloyl-galactopyranose and tetra-O-pivaloyl-galactopyranosyl bromide after electrophilic activation reacted with 6-O-protected 2-azido-galactosides to give the precursor structures of the Thomsen-Friedenreich antigen disaccharide with high regioselectivity, but low yield.With 4,6-Obenzylidene protected 2-azidogalactosides and 2-O-pivaloyl phenylthio galactosides, T-antigen disaccharides of this type were obtained in good yields. Glycosylation reactions of 4,6-O-benzylidene protected glucosamine derivatives with O-pivaloyl protected galactosyl bromide efficiently gave lactolactosamine disaccharides. Even a thioglycoside was efficiently galactosylated by this method resulting in the formation of a disaccharide thioglycoside useful itself as a potential glycosyl donor.

    Penta-O-pivaloyl-galactopyranose和tetra-O-pivaloyl-galactopyranosyl溴在亲电活化后与6-O-保护的2-azido-galactosides反应,高选择性地形成Thomsen-Friedenreich抗原二糖的前体结构,但产率较低。使用4,6-Obenzylidene保护的2-azidogalactosides和2-O-pivaloyl苯硫基半乳苷,可以得到这种类型的T-抗原二糖,产率较高。4,6-O-benzylidene保护的葡萄糖氨基衍生物与O-pivaloyl保护的半乳苷溴的糖基化反应有效地产生了乳糖氨二糖。甚至通过这种方法,一种硫代糖苷也可以有效地被半乳苷化,形成一种作为潜在糖基供体的二糖硫代糖苷。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物